The influence of drug treatment on the QoL of people with diabetes
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2020 |
| Outros Autores: | , , , , |
| Tipo de documento: | Artigo |
| Idioma: | por eng |
| Título da fonte: | Revista Brasileira em Promoção da Saúde |
| Texto Completo: | https://ojs.unifor.br/RBPS/article/view/10125 |
Resumo: | Objective: To analyze adherence to drug treatment in people with diabetes and its relationship to quality of life. Methods: This cross-sectional study was carried out with 350 people with diabetes in the municipality of Lajeado, Rio Grande do Sul, Brazil. Data were collected through the Measurement of Adherence to Treatment (MAT) and the WHOQoL-bref questionnaires, which were administered at the participants’ homes during the year 2015. Results: Most of the people with diabetes analyzed take the oral antidiabetic drug metformin (n=305; 87.1%), followed by glibenclamide (n=151; 43.1%), and 20.9% (n=73) use insulin. The majority takes simvastatin (n=259; 74%), acetylsalicylic acid (ASA) (n=203; 58%), enalapril (n=192; 55%), and hydrochlorothiazide (n=180; 52%). This population group positively adheres to the drug treatment regime for the control of the disease the mean overall quality of life is good (67.6±18.1). The mean quality of life score among people who adhere to drug the treatment is higher (68.6±15.9) compared to those who do not (60.9±14.2) (t=3.3162; p= 0.0012). Conclusion: In this sample of people with diabetes, those who exhibited good adherence to the drug treatment regime for the control of the disease also presented better quality of life compared to those who exhibited poor adherence to the drug treatment. |
| id |
UFOR-2_d1ed1cb6175e4c4c83ee4ddd04e257e6 |
|---|---|
| oai_identifier_str |
oai:ojs.ojs.unifor.br:article/10125 |
| network_acronym_str |
UFOR-2 |
| network_name_str |
Revista Brasileira em Promoção da Saúde |
| repository_id_str |
|
| spelling |
The influence of drug treatment on the QoL of people with diabetesLa influencia del tratamiento farmacológico para la calidad de vida de personas con diabetesA influência do tratamento medicamentoso na qualidade de vida de diabéticosDiabetes MellitusPrimary Health CareHealth PromotionDiabetes MellitusAtención Primaria de SaludPromoción de la SaludDiabetes MellitusAtenção Básica à SaúdePromoção da saúdeObjective: To analyze adherence to drug treatment in people with diabetes and its relationship to quality of life. Methods: This cross-sectional study was carried out with 350 people with diabetes in the municipality of Lajeado, Rio Grande do Sul, Brazil. Data were collected through the Measurement of Adherence to Treatment (MAT) and the WHOQoL-bref questionnaires, which were administered at the participants’ homes during the year 2015. Results: Most of the people with diabetes analyzed take the oral antidiabetic drug metformin (n=305; 87.1%), followed by glibenclamide (n=151; 43.1%), and 20.9% (n=73) use insulin. The majority takes simvastatin (n=259; 74%), acetylsalicylic acid (ASA) (n=203; 58%), enalapril (n=192; 55%), and hydrochlorothiazide (n=180; 52%). This population group positively adheres to the drug treatment regime for the control of the disease the mean overall quality of life is good (67.6±18.1). The mean quality of life score among people who adhere to drug the treatment is higher (68.6±15.9) compared to those who do not (60.9±14.2) (t=3.3162; p= 0.0012). Conclusion: In this sample of people with diabetes, those who exhibited good adherence to the drug treatment regime for the control of the disease also presented better quality of life compared to those who exhibited poor adherence to the drug treatment.Objetivo: Analizar la adhesión de personas con diabetes para el tratamiento farmacológico y su relación con la calidad de vida. Métodos: Estudio transversal desarrollado con 350 personas con diabetes del municipio de Lajeado, Río Grande de Sur. La recogida de datos se dio a través de los cuestionarios Medida de Adhesión al Tratamiento (MAT) y el Whoqol-bref que han sido aplicados en el domicilio de los participantes durante el año 2015. Resultados: La mayoría de las personas con diabetes investigadas toma el fármaco oral para la diabetes metformina (n=305; 87,1%), seguido del glibenclamida (n=151; 43,1%) y el 20,9 % (n=73) usa la insulina. La mayoría toma la sinvastatina (n=259; 74%), el ácido acetilsalicílico (AAS) (n=203; 58%), el enalapril (n=192; 55%) y la hidroclorotiazida (n=180; 52%). Esa población tiene adhesión al tratamiento farmacológico para el control de la enfermedad y la media general de la calidad de vida es buena (67,6±18,1). La media de la calidad de vida de las personas que tiene adhesión al tratamiento farmacológico es mayor (68,6±15,9) de que las que no adhieren al tratamiento (60,9±14,2) (t=3,3162; p=0,0012). Conclusión: En esa muestra de diabéticos se constató que los que tienen mejor adhesión al tratamiento farmacológico para el control de la enfermedad también tienen mejor calidad de vida comparándolos con el grupo de menor adhesión a los fármacos.Objetivo: Analisar a adesão de pessoas diabéticas ao tratamento medicamentoso e sua relação com a qualidade de vida. Métodos: Estudo transversal desenvolvido com 350 pessoas com diabetes no município de Lajeado, Rio Grande do Sul. A coleta de dados ocorreu por meio dos questionários Medida de Adesão ao Tratamento (MAT) e Whoqol-bref, aplicados no domicílio dos participantes durante o ano de 2015. Resultados: A maioria das pessoas com diabetes investigadas toma o antidiabético oral metformina (n=305; 87,1%), seguido de glibenclamida (n=151; 43,1%), e 20,9 % (n=73) fazem uso de insulina. A maioria toma sinvastatina (n=259; 74%), ácido acetilsalicílico (AAS) (n=203; 58%), enalapril (n=192; 55%) e hidroclorotiazida (n=180; 52%). Essa população adere positivamente ao tratamento medicamentoso relativo ao controle da doença e a média geral de qualidade de vida é boa (67,6±18,1). A média de qualidade de vida das pessoas que aderem ao tratamento medicamentoso é maior (68,6±15,9) do que as que não aderem (60,9±14,2) (t=3,3162; p= 0,0012). Conclusão: Constatou-se nessa amostra de diabéticos que os que têm melhor adesão ao tratamento medicamentoso relativo ao controle da doença também apresentam uma melhor qualidade de vida quando comparados com o grupo que tem menor adesão aos medicamentos.Universidade de Fortaleza2020-12-02info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed Article""Avaliado pelos pares""Avaliado pelos pares"application/pdfapplication/pdfhttps://ojs.unifor.br/RBPS/article/view/1012510.5020/18061230.2020.10125Brazilian Journal in Health Promotion; Vol. 33 (2020)Revista Brasileña en Promoción de la Salud; Vol. 33 (2020)Revista Brasileira em Promoção da Saúde; v. 33 (2020)1806-1230reponame:Revista Brasileira em Promoção da Saúdeinstname:Universidade de Fortaleza (Unifor)instacron:UFORporenghttps://ojs.unifor.br/RBPS/article/view/10125/pdfhttps://ojs.unifor.br/RBPS/article/view/10125/pdf_1Copyright (c) 2020 Revista Brasileira em Promoção da Saúdeinfo:eu-repo/semantics/openAccessMoreschi, ClaudeteFoggiato de Siqueira, DaianaFelipe Pissaia, LuisStein Backes, DirceFernández Pombo, Carmen NeriRempel, Claudete2021-01-26T11:48:34Zoai:ojs.ojs.unifor.br:article/10125Revistahttps://periodicos.unifor.br/RBPS/oai1806-12301806-1222opendoar:2021-01-26T11:48:34Revista Brasileira em Promoção da Saúde - Universidade de Fortaleza (Unifor)false |
| dc.title.none.fl_str_mv |
The influence of drug treatment on the QoL of people with diabetes La influencia del tratamiento farmacológico para la calidad de vida de personas con diabetes A influência do tratamento medicamentoso na qualidade de vida de diabéticos |
| title |
The influence of drug treatment on the QoL of people with diabetes |
| spellingShingle |
The influence of drug treatment on the QoL of people with diabetes Moreschi, Claudete Diabetes Mellitus Primary Health Care Health Promotion Diabetes Mellitus Atención Primaria de Salud Promoción de la Salud Diabetes Mellitus Atenção Básica à Saúde Promoção da saúde |
| title_short |
The influence of drug treatment on the QoL of people with diabetes |
| title_full |
The influence of drug treatment on the QoL of people with diabetes |
| title_fullStr |
The influence of drug treatment on the QoL of people with diabetes |
| title_full_unstemmed |
The influence of drug treatment on the QoL of people with diabetes |
| title_sort |
The influence of drug treatment on the QoL of people with diabetes |
| author |
Moreschi, Claudete |
| author_facet |
Moreschi, Claudete Foggiato de Siqueira, Daiana Felipe Pissaia, Luis Stein Backes, Dirce Fernández Pombo, Carmen Neri Rempel, Claudete |
| author_role |
author |
| author2 |
Foggiato de Siqueira, Daiana Felipe Pissaia, Luis Stein Backes, Dirce Fernández Pombo, Carmen Neri Rempel, Claudete |
| author2_role |
author author author author author |
| dc.contributor.author.fl_str_mv |
Moreschi, Claudete Foggiato de Siqueira, Daiana Felipe Pissaia, Luis Stein Backes, Dirce Fernández Pombo, Carmen Neri Rempel, Claudete |
| dc.subject.por.fl_str_mv |
Diabetes Mellitus Primary Health Care Health Promotion Diabetes Mellitus Atención Primaria de Salud Promoción de la Salud Diabetes Mellitus Atenção Básica à Saúde Promoção da saúde |
| topic |
Diabetes Mellitus Primary Health Care Health Promotion Diabetes Mellitus Atención Primaria de Salud Promoción de la Salud Diabetes Mellitus Atenção Básica à Saúde Promoção da saúde |
| description |
Objective: To analyze adherence to drug treatment in people with diabetes and its relationship to quality of life. Methods: This cross-sectional study was carried out with 350 people with diabetes in the municipality of Lajeado, Rio Grande do Sul, Brazil. Data were collected through the Measurement of Adherence to Treatment (MAT) and the WHOQoL-bref questionnaires, which were administered at the participants’ homes during the year 2015. Results: Most of the people with diabetes analyzed take the oral antidiabetic drug metformin (n=305; 87.1%), followed by glibenclamide (n=151; 43.1%), and 20.9% (n=73) use insulin. The majority takes simvastatin (n=259; 74%), acetylsalicylic acid (ASA) (n=203; 58%), enalapril (n=192; 55%), and hydrochlorothiazide (n=180; 52%). This population group positively adheres to the drug treatment regime for the control of the disease the mean overall quality of life is good (67.6±18.1). The mean quality of life score among people who adhere to drug the treatment is higher (68.6±15.9) compared to those who do not (60.9±14.2) (t=3.3162; p= 0.0012). Conclusion: In this sample of people with diabetes, those who exhibited good adherence to the drug treatment regime for the control of the disease also presented better quality of life compared to those who exhibited poor adherence to the drug treatment. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020-12-02 |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion "Peer-reviewed Article" "Avaliado pelos pares" "Avaliado pelos pares" |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://ojs.unifor.br/RBPS/article/view/10125 10.5020/18061230.2020.10125 |
| url |
https://ojs.unifor.br/RBPS/article/view/10125 |
| identifier_str_mv |
10.5020/18061230.2020.10125 |
| dc.language.iso.fl_str_mv |
por eng |
| language |
por eng |
| dc.relation.none.fl_str_mv |
https://ojs.unifor.br/RBPS/article/view/10125/pdf https://ojs.unifor.br/RBPS/article/view/10125/pdf_1 |
| dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Revista Brasileira em Promoção da Saúde info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Copyright (c) 2020 Revista Brasileira em Promoção da Saúde |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Universidade de Fortaleza |
| publisher.none.fl_str_mv |
Universidade de Fortaleza |
| dc.source.none.fl_str_mv |
Brazilian Journal in Health Promotion; Vol. 33 (2020) Revista Brasileña en Promoción de la Salud; Vol. 33 (2020) Revista Brasileira em Promoção da Saúde; v. 33 (2020) 1806-1230 reponame:Revista Brasileira em Promoção da Saúde instname:Universidade de Fortaleza (Unifor) instacron:UFOR |
| instname_str |
Universidade de Fortaleza (Unifor) |
| instacron_str |
UFOR |
| institution |
UFOR |
| reponame_str |
Revista Brasileira em Promoção da Saúde |
| collection |
Revista Brasileira em Promoção da Saúde |
| repository.name.fl_str_mv |
Revista Brasileira em Promoção da Saúde - Universidade de Fortaleza (Unifor) |
| repository.mail.fl_str_mv |
|
| _version_ |
1808844185806045184 |